Park Medi World Ipo
Park Medi World IPO Review & Key Points
Review: May Apply
Rating: 3
IPO Lead Managers aka Merchant Bankers
Nuvama Wealth Management Limited
CLSA India Private Limited
DAM Capital Advisors Limited
Intensive Fiscal Services Private Limited
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 92 | ₹14,904 |
| Retail Maximum | 13 | 1,196 | ₹1,93,752 |
| S-HNI Minimum | 14 | 1,288 | ₹2,08,656 |
| S-HNI Maximum | 67 | 6,164 | ₹9,98,568 |
| B-HNI Minimum | 68 | 6,256 | ₹10,13,472 |
| Investor Category | Share Offered | -% Shares |
| Anchor Investor | 17,037,036 Shares | -% |
| QIB (Ex. Anchor) | – Shares | 50% |
| NII Shares Offered | – Shares | 15% |
| Retail Shares Offered | – Shares | 35% |
| Anchor Bidding Date | December 9, 2025 |
| Anchor Investors List | |
| Shares Offered | 17,037,036 Shares |
| Anchor Size | 276.00 Cr. |
| lock-in period end date 50% shares (30 Days) | January 14, 2026 |
| lock-in period end date 50% shares (90 Days) | March 15, 2026 |
| IPO Open Date: | December 10, 2025 |
| IPO Close Date: | December 12, 2025 |
| Basis of Allotment: | December 15, 2025 |
| Refunds: | December 16, 2025 |
| Credit to Demat Account: | December 16, 2025 |
| IPO Listing Date: | December 17, 2025 |
| IPO Bidding Cut-off Time: | December 12, 2025 – 5 PM |
| Particular | Shares | % Share |
| Promoter Holding Pre Issue | 38,43,99,990 | 95.55% |
| Promoter Holding Post Issue | 43,19,30,854 | 82.89% |
| Purpose | Crores |
| Repayment/ prepayment, in full or in part, of certain outstanding borrowings availed by the Company and certain of the Subsidiaries. | ₹380.00 |
| Funding capital expenditure for development of new hospital and expansion of existing hospital by our certain Subsidiaries Park Medicity (NCR) and Blue Heavens, respectively. | ₹60.50 |
| Funding capital expenditure for purchase of medical equipment by the Company and our certain Subsidiaries, Blue Heavens and Ratangiri. | ₹27.46 |
| Unidentified inorganic acquisitions and general corporate purposes. | ₹- |
| Period Ended | Revenue | Expense | PAT | Assets |
| 2023 | ₹1,272.18 | ₹955.37 | ₹228.19 | ₹1,592.83 |
| 2024 | ₹1,263.08 | ₹1,041.66 | ₹152.01 | ₹1,912.10 |
| 2025 | ₹1,425.97 | ₹1,139.30 | ₹213.22 | ₹2,133.70 |
| September 2025 | ₹823.39 | ₹649.50 | ₹139.14 | ₹2,320.93 |
| KPI | Values |
| ROE: | 20.68% |
| ROCE: | 17.47% |
| EBITDA Margin: | 26.71% |
| PAT Margin: | 15.30% |
| Debt to equity ratio: | 0.61 |
| Earning Per Share (EPS): | ₹5.55 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 20.08% |
| Net Asset Value (NAV): | ₹26.58 |
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Apollo Hospitals Enterprise Limited | 100.56 | 73.43 | 17.63% | 570.37 | 21,994.30 Cr. |
| Fortis Healthcare Limited | 10.26 | 90.42 | 8.69% | 118.06 | 7,849.70 Cr. |
| Narayana Hrudalaya Limited | 38.90 | 50.10 | 21.80% | 177.37 | 5,575.00 Cr. |
| Max Healthcare Institute Limited | 11.07 | 101.54 | 11.47% | 96.50 | 7,184.10 Cr. |
| Krishna Institute of Medical Sciences Limited | 9.61 | 69.53 | 17.89% | 53.43 | 3,067.00 Cr. |
| Global Health Limited | 17.92 | 66.41 | 14.27% | 125.64 | 3,771.40 Cr. |
| Jupiter Lifeline Hospitals Ltd | 29.47 | 48.59 | 14.27% | 206.85 | 1,290.20 Cr. |
| Yatharth Hospital & Trauma Care Services Limited | 14.72 | 52.85 | 8.15% | 166.62 | 896.70 Cr. |
| IPO Open Date | December 10, 2025 |
| IPO Close Date | December 12, 2025 |
| Face Value | ₹2 Per Equity Share |
| IPO Price Band | ₹154 to ₹162 Per Share |
| Issue Size | Approx ₹920 Crores |
| Fresh Issue | Approx ₹770 Crores |
| Offer for Sale: | Approx 92,59,259 Equity Shares |
| Issue Type | Book Built Issue |
| IPO Listing | BSE, NSE |
| DRHP Draft Prospectus | |
| RHP Draft Prospectus |